HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC lessened its stake in HealthEquity, Inc. (NASDAQ:HQY) by 53.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,455 shares of the company’s stock after selling 6,216 shares during the period. SG Americas Securities LLC’s holdings in HealthEquity were worth $523,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Holocene Advisors LP acquired a new stake in shares of HealthEquity during the third quarter worth $1,246,000. GSA Capital Partners LLP purchased a new position in HealthEquity during the 3rd quarter worth $638,000. Natixis Advisors LLC lifted its stake in shares of HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after acquiring an additional 48,009 shares during the period. Vaughan Nelson Investment Management L.P. boosted its holdings in shares of HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Finally, Loomis Sayles & Co. L P increased its stake in shares of HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after acquiring an additional 24,665 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on HQY shares. The Goldman Sachs Group initiated coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. BTIG Research increased their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Barrington Research boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, JMP Securities upped their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now owns 66,469 shares in the company, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

NASDAQ:HQY opened at $110.42 on Friday. The company has a market cap of $9.57 billion, a P/E ratio of 101.30, a P/E/G ratio of 1.91 and a beta of 0.54. The firm’s 50 day moving average is $100.09 and its two-hundred day moving average is $88.41. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $111.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm posted $0.40 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.